null Mireia Arnedo
Ph.D. in Virology of HIV & Antirretroviral resistance, University of Barcelona (2004).
Postdoctoral Fellow on HIV and Pharmacogenomics at CHUV, Lausanne-Switzerland (2004 - 2006).
Master in Leadership and Management in Science and Innovation. Universidad Pompeu Fabra. Barcelona School of Management (2013).
Research accreditation as Tenured assistant professor issued by lAgència per a la Qualitat del Sistema Universitari de Catalunya (AQU) (2014 - present).
Investigator of Health National System, Instituto de Salud Carlos III (ISCIII). IDIBAPS - Hospital Clínic Barcelona, Spain. Coordinator of AIDS HIVACAT Research lab located at the Parc Científic of Barcelona (PCB)/IDIBAPS (2007-2012).
Associate Investigator I3-IDIBAPS. ISCIII, Health Catalan System. Generalitat de Catalunya (2013 - present).
Professor at Master of SIDA, University of Barcelona (2003 - present).
Professor at Master in Treatment and HIV Pathogenesis, University Autonoma de Barcelona-Irsicaixa-Nursery School of Physiotherapy Gimbernat University in collaboration with the Institute for Research of AIDS Irsicaixa and the Ragon Institute (MGH, MIT and Harvard University); (2012 - present).
Professor at Master in Anàlisi de Dades Òmiques, University of VIC (2012- present).
Member of the Biomedicine Ph.D. Program at UB (2010 - present).
Review editor of Frontiers in Pharmacogenetics and Pharmacogenomics; Antiviral Therapy; HIV Medicine; Plos; AIDS. Member National Evaluation and Foresight Agency (ANEP) (2010 - present). Member of the Member of National AIDS Network (RIS).